This article has been updated from a previous version to include additional comments from Cliff Reid regarding the expected cost of Complete's services.

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) - Complete Genomics is on the cusp of launching its commercial operations and is aiming to sequence several thousand human genomes this year — and potentially up to a million human genomes over the next five years — company officials told investors Wednesday at the JP Morgan Healthcare Conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.